In our previous work, Liu et al. implys that lung injury severity was associated with ACE activity and angiotensin II level in an experimental lipopolysaccharide (LPS)—induced acute lung injury (ALI) model, but was ameliorated by using losartan, an ACE inhibitor [19]. The gene discussed is ACE; the disease is acute lung injury.